jsp191
mAbexperimental
Clinical trial activity
11 trials · 8 clinical orgs · 0 marketing orgs
Phase 1
9
Phase 2
7
Phase 3
0
Phase 4
0
Earliest trial started Jun 15, 2020 (NCT04429191)
Timeline
Indications
Studied for
- Anemia, Sickle Cell · Phase 1/Phase 2
- Asthma · Phase 1
- beta-Thalassemia · Phase 1/Phase 2
- Chronic Urticaria · Phase 2
- Fanconi Anemia · Phase 1/Phase 2
- GATA2 Transcription Factor · Phase 2
- Granulomatous Disease, Chronic · Early Phase 1
- Leukemia, Myeloid, Acute · Phase 1
- Myelodysplastic Syndromes · Phase 1
- Primary Immunodeficiency Diseases · Phase 2
Mechanism of action
- Stem cell growth factor receptorINHIBITOR
KIT inhibitor
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL5095110 ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06736262 | Phase 2 | Nov 26, 2024 | Jasper Therapeutics, Inc. |
| NCT06592768 | Phase 1 | Sep 16, 2024 | Jasper Therapeutics, Inc. |
| NCT06353971 | Phase 1/Phase 2 (Phase 2) | Mar 18, 2024 | Jasper Therapeutics, Inc. |
| NCT06145282 | Phase 1/Phase 2 (Phase 2) | Jan 3, 2024 | National Heart, Lung, and Blood Institute (NHLBI) |
| NCT05907746 | Phase 2 | Nov 29, 2023 | National Cancer Institute (NCI) |
| NCT06162728 | Phase 1/Phase 2 (Phase 2) | Nov 29, 2023 | Jasper Therapeutics, Inc. |
| NCT05903274 | Phase 1 | Jun 19, 2023 | Jasper Therapeutics, Inc. |
| NCT05600907 | Early Phase 1 (Phase 1) | Dec 29, 2022 | National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT05357482 | Phase 1/Phase 2 (Phase 2) | May 12, 2022 | National Heart, Lung, and Blood Institute (NHLBI) |
| NCT04784052 | Phase 1/Phase 2 (Phase 2) | Oct 31, 2021 | Stanford University |
| NCT04429191 | Phase 1 | Jun 15, 2020 | City of Hope National Medical Center, Jasper Therapeutics, Inc., Stanford University, University of Utah, University of Washington |
Showing 11 of 11 trials
Page 1 / 1
Organizations
Research & Development (8)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Jasper Therapeutics, Inc. | For profit | 6 | 6 | 2 | 2020 |
| National Heart, Lung, and Blood Institute (NHLBI) | Government | 2 | 2 | 1 | 2022 |
| Stanford University | Academic/Hospital | 2 | 1 | 2 | 2020 |
| City of Hope National Medical Center | Academic/Hospital | 1 | 0 | 1 | 2020 |
| National Cancer Institute (NCI) | Government | 1 | 1 | 1 | 2023 |
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 1 | 1 | 1 | 2022 |
| University of Utah | Academic/Hospital | 1 | 0 | 1 | 2020 |
| University of Washington | Academic/Hospital | 1 | 0 | 1 | 2020 |
8 organizations
Page 1 / 1